Figure 2.
Design of selected clinical trials of PROTAC degraders. PK: pharmacokinetic; PD: pharmacodynamic; RP2D: recommended phase II dose; CDK4/6: cyclin dependent kinase 4/6
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.